Recent data implicate steroid receptor coactivator-1 (SRC-1) as a key molecular mediator linking corticosteroid signaling to immune regulation and tumor recurrence, highlighting a novel microenvironmental mechanism independent of steroid dose. Here, NCOA1 is linked to neoplasm.